Corrigendum to "Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study" [Diabetes Res. Clin. Pract. 186 (2022) 109816]
Diabetes Res Clin Pract. 2024 Dec:218:111925.
doi: 10.1016/j.diabres.2024.111925.
Epub 2024 Nov 24.
1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Medical Nutrition Therapy, Chang Gung Memorial Hospital, Linkou, Taiwan.
4 Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
6 Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu, Taiwan. Electronic address: [email protected].